Premarket Decliner
GUTS Fractyl Health1.83-0.29-13.7%
Premarket:1.20-0.63 (-34.4%)
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita After GLP-1 Discontinuation
Globe NewswireThu, 29-Jan 7:00 AM
GUTS Fractyl Health1.87+0.01+0.5%
Premarket:1.01-0.86 (-46.0%)
Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering
Globe NewswireWed, 6-Aug 8:30 AM
GUTS Fractyl Health2.14+0.23+12.0%
Premarket:1.64-0.50 (-23.4%)
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
Globe NewswireMon, 23-Jun 7:40 AM
GUTS Fractyl Health7.40+0.20+2.8%
Premarket:5.88-1.52 (-20.5%)
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Globe NewswireMon, 1-Apr 7:00 AM
